Dr. Fiona Greer
Independent Consultant & Roundtable Chair
Following a Ph.D. in Protein Biochemistry from Aberdeen University (1984) Fiona became a founding Director of M-Scan. Upon their acquisition in 2010, she became Global Director, Biopharma Services Development, SGS. With over 35 years’ experience in glycoprotein analysis she has been involved with a diverse range of biotechnology products, both novel and biosimilar, and now consults to companies worldwide.
Dr. Richard Easton
Technical Director for Structural Analysis
Richard obtained his PhD in glycoprotein structural characterization using mass spectrometry from Imperial College of Science, Technology and Medicine. Following postdoctoral research in the field of glycan elucidation, Richard worked at GlaxoSmithKline and then M-Scan Limited, where he held the position of Principal Scientist. At BioPharmaSpec, Richard manages all aspects of carbohydrate and glycoprotein characterization.
Founder and President
Dan is founder and president of Toronto-based contract testing laboratory Custom Biologics, a global service provider of functional testing and characterization of biotherapeutics, biosimilars and antibody drug conjugates. Dan has a background in microbiology, immunology, and protein biochemistry and over 20 years’ experience in developing and validating reliable and reproducible cell-based bioassays to measure the functional properties of biotherapeutic drugs.
Marius obtained his doctoral degree in physical chemistry from Universität Konstanz. He subsequently worked with virus-like particles as a Postdoctoral Research Scientist at the National Center of Molecular Hydrodynamics in Nottingham. In 2015, he joined Coriolis Pharma, where he led the AUC and AF4 unit. Marius cofounded ZentriForce Pharma Research GmbH in 2019, a CRO with expertise in hydrodynamic analysis techniques.